BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1159621)

  • 1. Elimination kinetics of sulfadiazine in patients with normal and impaired renal function.
    Ohnhaus EE; Spring P
    J Pharmacokinet Biopharm; 1975 Jun; 3(3):171-9. PubMed ID: 1159621
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of a sulfadiazine-trimethoprim combination.
    Bergan T; Vik-Mo H; Anstad U
    Clin Pharmacol Ther; 1977 Aug; 22(2):211-24. PubMed ID: 884922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic studies with trimethoprim and different doses of sulfadiazine in healthy human subjects.
    Männistö P; Tuomisto J; Saris NE; Lehtinen T
    Chemotherapy; 1973; 19(5):289-98. PubMed ID: 4595634
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses.
    Nouws JF; Firth EC; Vree TB; Baakman M
    Am J Vet Res; 1987 Mar; 48(3):392-402. PubMed ID: 3565894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum half-lives and elimination rates of a new semi-synthetic cephalosporin, cephacetrile, in nephrectomized patients and in patients with impaired or normal renal function.
    Reutter F; Maurice NP
    Arzneimittelforschung; 1974 Sep; 24(9b):1466-8. PubMed ID: 4479804
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of tetroxoprim/sulphadiazine in patients with impaired renal function.
    Reutter FW; Vergin H; Sieber R; Ferber H
    J Antimicrob Chemother; 1979 Nov; 5(B):149-58. PubMed ID: 536339
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin half-life in normal and impaired renal function.
    Perry PJ; Herron GR; King JC
    Clin Pharmacol Ther; 1974 Sep; 16(3):514-9. PubMed ID: 4413659
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of sulfadiazine and trimethoprim in man.
    Andreasen F; Elsborg L; Husted S; Thomsen O
    Eur J Clin Pharmacol; 1978 Nov; 14(1):57-67. PubMed ID: 729608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of sulfadiazine in children with protein calorie malnutrition.
    Mehta S; Nain CK; Sharma B; Mathur VS
    Pharmacology; 1980; 21(6):369-74. PubMed ID: 6784129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and multiple dose kinetics of co-tetroxazine and co-trimoxazole in patients.
    Vergin H; Ferber H; Zimmermann I; Neurath GB
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):350-7. PubMed ID: 6975762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tetroxoprim and sulphadiazine in various species.
    Vergin H; Fritschi E
    J Antimicrob Chemother; 1979 Nov; 5(B):103-18. PubMed ID: 536336
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioavailability of sulfadiazine solutions, suspensions, and tablets in humans.
    Meyer MC; Straughn AB; Ramachander G; Cavagnol JC; Biola Mabadeje AF
    J Pharm Sci; 1978 Dec; 67(12):1659-61. PubMed ID: 581498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of low dose sulfadiazine in patients with renal failure.
    Seppänen J; Viranta M; Julkunen R; Wilén G
    Ann Clin Res; 1980; (25):31-7. PubMed ID: 7377747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of pharmacokinetic models for sulfonamides in food animals: metabolic depletion profile of sulfadiazine in the calf.
    Woolley JL; Sigel CW
    Am J Vet Res; 1982 May; 43(5):768-74. PubMed ID: 7091837
    [No Abstract]   [Full Text] [Related]  

  • 15. Variability in the elimination of trisulfapyrimidines in man.
    Mathur LK; Colaizzi JL; Jaffe JM; Poust RI; Shah VP
    Biopharm Drug Dispos; 1983; 4(2):191-4. PubMed ID: 6882886
    [No Abstract]   [Full Text] [Related]  

  • 16. [Estimation of residual rate and apparent half-life time of drugs using the method of acute mortality of animals].
    He MS; Zhan LF; Guo JY; Zhang YZ
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):213-6. PubMed ID: 2943131
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfadiazine handling in the rabbit. II. Mechanisms of nonlinear kinetics of elimination.
    du Souich P; McLean AJ; Lalka D; Vicuna N; Chauhuri E; McNay JL
    J Pharmacol Exp Ther; 1978 Oct; 207(1):228-35. PubMed ID: 702344
    [No Abstract]   [Full Text] [Related]  

  • 18. Acetylator phenotype determination in the rabbit: sulphamethazine or sulphadiazine, the choice of a substrate.
    du Souich P; Courteau H
    J Pharm Pharmacol; 1981 Apr; 33(4):261-3. PubMed ID: 6115918
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug metabolism in malnourished children.
    Mehta S; Nain CK; Sharma B; Mathur VS
    Prog Clin Biol Res; 1981; 77():739-46. PubMed ID: 6801701
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function.
    Bergan T; Brodwall EK; Vik-Mo H; Anstad U
    Infection; 1979; 7 Suppl 4():S382-7. PubMed ID: 511352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.